- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2009
- Public Summary Document (PSD) March 2009 PBAC Meeting - PDF
Adalimumab – March 2009
Adalimumab, injection, 40 mg in 0.8 mL pre-filled syringe, 40 mg in 0.8 mL pre-filled pen, Humira®, March 2009
Last updated
3 July 2009